A £130 million investment from the government will be pumped into new technologies to help improve treatment, diagnosis and care options for a number of life-changing diseases.
It was announced on 9 September that the money would be invested in treatments for arthritis and cancer, as well as gene-based therapies for diseases including dementia and Parkinson’s.
This includes £50m that will go towards NHS diagnostic services and support the work of existing ‘centres of excellence’ in digital pathology and imaging, using artificial intelligence (AI).
The centres, which are based in Leeds, Oxford, Coventry and London, will be able to partner with more NHS trusts and further develop “cutting-edge” products using digital systems and AI that could ultimately save lives.
They were established in November 2018 by UKRI, which will allocate the £50 million via a competition run between the four centres.
The bids must demonstrate how funding will be used to invest in digital infrastructure and equipment in partner NHS trusts, and digitally link these trusts to the centres.
Secretary of state for health and social care, Matt Hancock, said: “We’ve got to bring NHS technology into the 21st century. I’ve seen for myself how better technology and diagnosis can save clinicians’ time so they can concentrate on care.
“The NHS is now spearheading world-leading technologies that can transform and save lives through new treatments, diagnosis techniques and care.
“I’m determined that the benefits of these advances will improve the lives of thousands of patients whose conditions have long been considered life-limiting.”
A further £7.5m will be invested in implementing innovations that allow more people to receive care from the comfort of their own home, with the aim of improving the delivery of social care across the UK.
Minister for innovation, Nicola Blackwood, said the funding would help “deliver on the NHS’s international leadership on applying artificial intelligence to complex health problems”.
其中包括5000万英镑将用于 NHS 诊断服务，并利用人工智能( AI )支持现有数字病理和成像“卓越中心”的工作。
这些中心位于利兹、牛津、考文垂和伦敦，将能够与更多 NHS 信托公司合作，并利用数字系统和人工智能进一步开发“前沿”产品，最终挽救生命。
投标必须证明资金将如何用于投资 NHS 合作伙伴信托的数字基础设施和设备，并将这些信托数字连接到这些中心。
美国卫生和社会福利部长马特•汉考克( Matt Hancock )表示：“我们必须将 NHS 技术带入21世纪。我亲眼看到，更好的技术和诊断可以节省临床医生的时间，使他们能够集中精力于护理。
“ NHS 正在引领世界领先的技术，通过新的治疗、诊断技术和护理来改变和拯救生命。
创新部长尼古拉•布莱克伍德( Nicola Blackwood )表示，这笔资金将有助于“发挥 NHS 在将人工智能应用于复杂健康问题方面的国际领导作用”。